ClinicalTrials.Veeva

Menu

A NEW SCORING SYSTEM FOR PREDICTION OF PDA (SIMPLE)

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Unknown

Conditions

Prematurity; Extreme
Patent Ductus Arteriosus

Study type

Observational

Funder types

Other

Identifiers

NCT04270240
MAEEAH6725

Details and patient eligibility

About

Patent ductus arteriosus (PDA) is an important morbidity of that the diagnosis and treatment is controversy in premature infants. A number of scoring systems have been developed, including the findings of echocardiography on the diagnosis and treatment of PDA. This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.

Full description

This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.

Enrollment

100 estimated patients

Sex

All

Ages

Under 15 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • informed consent obtained from parents
  • extremely preterm infants
  • infants born before 28 gestational week

Exclusion criteria

  • lack of informed consent
  • chromosomal abnormality
  • cardiovascular abnormality

Trial contacts and locations

1

Loading...

Central trial contact

Merih Y Cetinkaya; Seda Y Semerci

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems